David A. Wenger
Department of Neurology
1020 Locust St.
Room 394
Jefferson Medical College
USA
Name/email consistency: high
- Generation of transgenic mice expressing insulin-like growth factor-1 under the control of the myelin basic protein promoter: increased myelination and potential for studies on the effects of increased IGF-1 on experimentally and genetically induced demyelination. Luzi, P., Zaka, M., Rao, H.Z., Curtis, M., Rafi, M.A., Wenger, D.A. Neurochem. Res. (2004)
- Insights into the diagnosis and treatment of lysosomal storage diseases. Wenger, D.A., Coppola, S., Liu, S.L. Arch. Neurol. (2003)
- Murine, canine and non-human primate models of Krabbe disease. Wenger, D.A. Mol. Med. Today (2000)
- Globoid cell leukodystrophy in cairn and West Highland white terriers. Wenger, D.A., Victoria, T., Rafi, M.A., Luzi, P., Vanier, M.T., Vite, C., Patterson, D.F., Haskins, M.H. J. Hered. (1999)